Bio

Over 20 years experience in investment banking, corporate banking and private equity/venture capital. Extensive senior-level transaction and private growth company experience. Formerly Partner at Gordon Capital Corporation (now part of HSBC Securities) and Vice-President, Investment Banking at First Marathon Securities (now National Bank Financial). Brad also spent a number of years providing portfolio and investment management services to an Ontario labour-sponsored venture capital fund and a private capital pool. Brad then worked with two proprietary, patented technology startups based in the U.S., in Florida and Alabama, to create and execute commercialization, intellectual property, operational and capital strategies before co-founding Sapient. Brad was formally trained and gained valuable and broad analytical / transaction experience at some of the leading North American financial institutions such as CIBC World Markets in Toronto; Bank of America in San Francisco; and Chemical Bank / Chemical Venture Partners (now part of JPMorgan Chase & Co.) in New York. Graduate of University of Chicago Booth School of Business, with highest honors in 1995. Brad has long specialized in small cap, private and early- and growth-stage companies, both as advisor and principal. He has also served on a number of boards of directors and advisory boards of such companies, currently serving on the advisory board of NovaVive Inc., a privately owned animal health immunobiology company based in Napanee, Ontario. He has been involved in numerous financings & buyouts, mergers & acquisitions, divestitures, restructurings and other transactions in a variety of industries including enterprise application & infrastructure software, a wide range of technology & internet, healthcare (biotech, healthcare services, health & wellness), telecom, aerospace, manufacturing, industrial products, consumer products, retail, chemicals, media & entertainment, business process outsourcing (BPO), automotive, resources and financial services. His clients have stretched across Canada and the U.S. Brad has experience and insight in analyzing and structuring transactions gained from his involvement with unique and ground-breaking transactions such as the first institutional non-recourse financing of a major entertainment act, the world tours of the Rolling Stones and Pink Floyd in 1994; the first and largest “bought-deal” IPO ever done in Canada with Sherritt International in 1995, raising $359 million for the expansion of its diverse Cuba-based businesses; and the first Canadian IPO of a successful China-based oil & gas pure play in 1996 with Pendaries Petroleum; in addition to working on major international transactions with Richard Li’s Pacific Century Group.